We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.80
Bid: 33.00
Ask: 33.45
Change: -0.10 (-0.30%)
Spread: 0.45 (1.364%)
Open: 33.00
High: 33.35
Low: 32.70
Prev. Close: 32.90
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: Notification of major holdings

28 Apr 2021 09:31

RNS Number : 8669W
Futura Medical PLC
28 April 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0033278473

Issuer Name

FUTURA MEDICAL PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

HT Riverwood Multi-Growth Fund

City of registered office (if applicable)

George Town

Country of registered office (if applicable)

Cayman Islands

4. Details of the shareholder

Is the shareholder the same as the person subject to the notification obligation, above?

Yes

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

21-Apr-2021

6. Date on which Issuer notified

21-Apr-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.102000

0.000000

3.102000

7940000

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0033278473

7940000

3.102000

Sub Total 8.A

7940000

3.102000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

HT Riverwood Multi-Growth Fund

HT Riverwood Multi-Growth Fund

3.102000

3.102000

10. In case of proxy voting

Is there proxy voting?

No

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

N/A

12. Date of Completion

27-Apr-2021

13. Place Of Completion

Hong Kong

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFIFFTSDITFIL
Date   Source Headline
26th Nov 20186:00 pmRNSApplication for Block Listing
19th Nov 20183:43 pmRNSHolding(s) in Company
19th Nov 20182:29 pmRNSHolding(s) in Company
19th Nov 20182:24 pmRNSHolding(s) in Company
19th Nov 201811:03 amRNSDirectors' / PDMR Dealing and Grant of Options
15th Nov 201811:36 amRNSHolding(s) in Company
13th Nov 20187:00 amRNSDirector/PDMR Dealings
12th Nov 20182:17 pmRNSResult: Open Offer General Meeting & Voting Rights
9th Nov 20187:00 amRNSPresents Data on MED2005 at SMSNA Annual Meeting
6th Nov 20188:29 amRNSHolding(s) in Company
31st Oct 20187:00 amRNS1st Patient Enrolled in European Ph3 MED2002 study
24th Oct 201810:19 amRNSPosting of Circular and Notice of General Meeting
19th Oct 20189:05 amRNSSecond Price Monitoring Extn
19th Oct 20189:00 amRNSPrice Monitoring Extension
19th Oct 20187:00 amRNSFurther Details on the Fundraising
18th Oct 20185:16 pmRNSOffer on PrimaryBid.com
18th Oct 20185:04 pmRNSProposed Fundraising
1st Oct 20187:00 amRNSHolding(s) in Company
26th Sep 20187:00 amRNSInterim Results for the Six Months 30 June 2018
24th Sep 20183:39 pmRNSTR-1: Notification of major holdings
24th Sep 20187:00 amRNSHolding(s) in Company
24th Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20184:41 pmRNSSecond Price Monitoring Extn
20th Sep 20184:35 pmRNSPrice Monitoring Extension
19th Sep 20189:05 amRNSSecond Price Monitoring Extn
19th Sep 20189:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSBusiness Update
29th Aug 20187:00 amRNSNotice of Interim Results
23rd Jul 20187:00 amRNSTPR 100: UK Regulatory Submission
13th Jun 20186:22 pmRNSResult of AGM
13th Jun 20187:00 amRNSAGM Statement
31st May 20186:20 pmRNSTotal Voting Rights
30th May 201810:20 amRNSBlock Listing Interim Review
25th May 20187:00 amRNSApplication for Block Listing
27th Apr 20185:11 pmRNSNotification of Major Interest in Shares
26th Apr 20187:00 amRNSPhase III efficacy study of MED2002
25th Apr 20187:00 amRNSPositive data from MED2002 PK study
6th Apr 201812:13 pmRNSNotice of AGM
14th Mar 20187:00 amRNSPreliminary Results
13th Mar 20187:00 amRNSPositive Interim Data from MED2002 PK study
20th Feb 20187:00 amRNSDirectorate Changes
15th Feb 20187:00 amRNSNotification of Preliminary Results
31st Jan 201810:39 amRNSTotal Voting Rights
4th Jan 20187:00 amRNSPublication of Positive MED2002 Clinical Data
3rd Jan 20183:08 pmRNSDirector/PDMR Shareholding
2nd Jan 20183:50 pmRNSRemuneration of Non-Executive Directors and TVR
29th Nov 20177:00 amRNSMED2002: Regulatory, Clinical & Commercial Update
29th Nov 20177:00 amRNSMED2002: PK Study Commences
24th Nov 20171:08 pmRNSBlock Listing Update
23rd Oct 20173:30 pmRNSPDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.